ARTICLE | Distillery Therapeutics
Therapeutics: CXC chemokine receptor 3 (CXCR3)
January 22, 2015 8:00 AM UTC
In vitro and mouse studies suggest antagonizing CXCR3 could help treat AD. In the mouse amyloid precursor protein (APP)/presenilin 1 (PSEN1; PS1) model of AD, CXCR3 knockout decreased amyloid plaque a...